CAS 610318-03-1

(R)​-​2-​[3-​[3-​[[2-​Chloro-​3-​(trifluoromethyl)​benzyl]​(2,​2-​diphenylethyl)​amino]​-​3-​methylpropoxy]​phenyl]​acetic acid hydrochloride

CAS : 610318-03-1

Formule : C₃₄H₃₄Cl₂F₃NO₃

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 632.5399

Ref: IN-DA01EOEB

RGX-104 hydrochloride

CAS : 610318-03-1

RGX-104 hydrochloride

Degré de pureté : ≥98%

Masse moléculaire : 632.54g/mol

Ref: 54-BUP01994

RGX-104 hydrochloride

CAS : 610318-03-1

RGX-104 hydrochloride (SB742881) is a small molecule LXR agonist that regulates innate immunity using transcriptional activation of the ApoE gene.

Formule : C₃₄H₃₄Cl₂F₃NO₃

Degré de pureté : 99.49%

Couleur et forme : Solid

Masse moléculaire : 632.54

Ref: TM-T5128

RX-104 hydrochloride

CAS : 610318-03-1

RX-104 hydrochloride is a novel, potent, and orally bioavailable anticancer agent that inhibits the synthesis of DNA by exerting its cytotoxic effect on tumor cells. The potential for RX-104 hydrochloride to induce myeloid-derived suppressor cells has been investigated in preclinical models. RX-104 hydrochloride has also demonstrated an ability to activate markers associated with tumor progression in cancer patients. This drug is activated by the enzymes cytochrome P450 3A4 and CYP2C8/9. It also activates markers of resistance to docetaxel, which may be due to the inhibition of myeloid-derived suppressor cells.

Formule : C₃₄H₃₄Cl₂F₃NO₃

Degré de pureté : Min. 95%

Masse moléculaire : 632.54 g/mol

Ref: 3D-KZA31803